The global atherectomy devices market is poised to record appreciable proceeds through the ensuing years, driven by the surging cases of patients suffering from ailments comprising obesity, atherosclerosis, hypertension, and diabetes.

A rise in the number of hospitalizations due to the influx of patients managing atrial plaque by means of surgical interventions and angioplasty is expected to drive the demand for atherectomy procedures over the estimated period.

Request for a sample copy of this report @ https://www.decresearch.com/request-sample/detail/2769  

On this note, according to the latest study by Global Market Insights, Inc., the atherectomy devices market share is expected to surpass USD 1 billion by 2027. This growth is attributed to an increase in acquisition and merger strategies by major atherectomy device companies.

For instance, in September 2020, AngioDynamics, Inc., a leading provider of minimally invasive medical devices, announced the roll-out of the Auryon Atherectomy System. The launched system is a newly-developed innovative technology for the treatment of PAD (Peripheral Artery Disease), comprising In-Stent Restenosis (ISR) and Critical Limb Ischemia (CLI).

The coronary applications segment is estimated to exhibit an appreciable CAGR of 12% through the estimated period. As per an article published in 2019, the CAC (coronary artery calcification) disease is highly prevalent in a patient having coronary heart disease.

CAC is individually associated with cardiovascular death risk in patients having chronic kidney disease. This is expected to increase the demand for atherectomy devices through the estimated period.

Brazil atherectomy devices market held nearly USD 7.0 million in 2020 and will register substantial growth due to the surging healthcare expenditure, increasing life expectancy, and preference for early diagnosis and non-invasive therapies for the treatment of pulmonary vascular diseases.

In addition, the key factors of risk associated with PAD (peripheral artery disease) comprising age, smoking, diabetes mellitus, and a sedentary lifestyle will boost Latin America atherectomy devices industry growth through the analysis period.

Request for customization @ https://www.decresearch.com/roc/2769

The overall market revenue from ambulatory surgical centers is likely to record a considerable growth of around 9.7% through the projected span. An improvement in the reimbursement scenarios associated with such procedures in these facilities is expected to bolster segment growth by 2027.

This rise is further driven by an increasing focus on a convenient environment, operational efficiency, highly efficient professionals, and the development of an inclusive ambulatory market strategic plan.

The orbital atherectomy devices market size accounted for more than 30% of the overall industry revenue in 2020 and is expected to grow on account of the capability of the product to enhance orbiting action and speed. This helps in decreasing a considerable amount of time in atherectomy procedures.

Orbital atherectomy devices like the Diamondback 360° Orbital Atherectomy System, combined with proprietary guide wire system, help in enhancing application in various conditions and facilitate the use of guide wires of configurable sizes.

Partial Chapter of the Table of Content:

Chapter 1.  Methodology

1.1. Market definitions

1.2. Base estimates & working

1.3. Forecast calculations

1.4. Data validation

1.5. Data sources

1.5.1.  Secondary

1.5.1.1.  Paid sources

1.5.1.2.  Unpaid sources

1.5.2.  Primary

Chapter 2.  Executive Summary

2.1. Atherectomy devices industry 360⁰ synopsis, 2016 - 2027

2.1.1.   Business trends

2.1.2.   Product trends

2.1.3.   Application trends

2.1.4.   End-use trends

Browse complete Table of Contents (ToC) of this research report @ https://www.decresearch.com/toc/detail/atherectomy-devices-market